• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于鼻腔给药的干粉流感疫苗制剂。

Formulation of a dry powder influenza vaccine for nasal delivery.

作者信息

Garmise Robert J, Mar Kevin, Crowder Timothy M, Hwang C Robin, Ferriter Matthew, Huang Juan, Mikszta John A, Sullivan Vincent J, Hickey Anthony J

机构信息

School of Pharmacy, University of North Carolina at Chapel Hill, CB# 7360 Kerr Hall Room 1310, 27599, Chapel Hill, NC.

Becton Dickinson Technologies, 27709, Research Triangle Park, NC.

出版信息

AAPS PharmSciTech. 2006 Mar;7(1):E131-E137. doi: 10.1208/pt070119. Epub 2017 Mar 8.

DOI:10.1208/pt070119
PMID:28290034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750726/
Abstract

The purpose of this research was to prepare a dry powder vaccine formulation containing whole inactivated influenza virus (VIIV) and a mucoadhesive compound suitable for nasal delivery. Powders containing WIIV and either lactose or trehalose were produced by lyophilization. A micro-ball mill was used to reduce the lyophilized cake to sizes suitable for nasal delivery. Chitosan flakes were reduced in size using a cryo-milling technique. Milled powders were sieved between 45 and 125 μm aggregate sizes and characterized for particle size and distribution, morphology, and flow properties. Powders were blended in the micro-ball mill without the ball. Lyophilization followed by milling produced irregularly shaped, polydisperse particles with a median primary particle diameter of ≈21 μm and a yield of ≈37% of particles in the 45 to 125 μm particle size range. Flow properties of lactose and trehalose powders after lyophilization followed by milling and sieving were similar. Cryo-milling produced a small yield of particles in the desired size range (<10%). Lyophilization followed by milling and sieving produced particles suitable for nasal delivery with different physicochemical properties as a function of processing conditions and components of the formulation. Further optimization of particle size and morphology is required for these powders to be suitable for clinical evaluation.

摘要

本研究的目的是制备一种含有全灭活流感病毒(VIIV)和适用于鼻腔给药的粘膜粘附化合物的干粉疫苗制剂。通过冻干法制备含有VIIV以及乳糖或海藻糖的粉末。使用微型球磨机将冻干饼研磨至适合鼻腔给药的尺寸。采用低温研磨技术减小壳聚糖薄片的尺寸。将研磨后的粉末筛分为聚集体尺寸在45至125μm之间的粉末,并对其粒度和分布、形态及流动性质进行表征。在无球的微型球磨机中混合粉末。冻干后再进行研磨得到形状不规则、多分散的颗粒,其初级颗粒直径中值约为21μm,在45至125μm粒径范围内颗粒产率约为37%。冻干后再进行研磨和筛分的乳糖和海藻糖粉末的流动性质相似。低温研磨在所需尺寸范围内(<10%)颗粒产率较低。冻干后再进行研磨和筛分得到适合鼻腔给药的颗粒,其物理化学性质因加工条件和制剂成分而异。为使这些粉末适合临床评估,需要进一步优化粒度和形态。

相似文献

1
Formulation of a dry powder influenza vaccine for nasal delivery.用于鼻腔给药的干粉流感疫苗制剂。
AAPS PharmSciTech. 2006 Mar;7(1):E131-E137. doi: 10.1208/pt070119. Epub 2017 Mar 8.
2
Formulation of a dry powder influenza vaccine for nasal delivery.用于鼻腔给药的干粉流感疫苗的配方。
AAPS PharmSciTech. 2006 Mar 10;7(1):E19. doi: 10.1208/pt070119.
3
Dry Formulations Enhanced Mucoadhesive Properties and Reduced Cold Chain Handing of Influenza Vaccines.干粉制剂增强流感疫苗的粘膜黏附性能并降低冷链处理要求。
AAPS PharmSciTech. 2018 Nov;19(8):3763-3769. doi: 10.1208/s12249-018-1181-2. Epub 2018 Sep 26.
4
Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.含海藻糖和亮氨酸的喷雾干燥流感抗原制成一种可雾化粉末疫苗制剂,经肺部给药后可诱导强烈的全身和黏膜免疫。
J Aerosol Med Pulm Drug Deliv. 2015 Oct;28(5):361-71. doi: 10.1089/jamp.2014.1176. Epub 2015 Feb 25.
5
Liposomal dry powders as aerosols for pulmonary delivery of proteins.用于蛋白质肺部递送的脂质体干粉气雾剂。
AAPS PharmSciTech. 2005 Dec 21;6(4):E641-8. doi: 10.1208/pt060480.
6
Effect of milling and sieving on functionality of dry powder inhalation products.研磨和筛分对干粉吸入产品功能的影响。
Int J Pharm. 2006 Feb 17;309(1-2):51-9. doi: 10.1016/j.ijpharm.2005.10.043. Epub 2005 Dec 27.
7
Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach.应用质量源于设计方法制备含左旋多巴的鼻腔干粉制剂。
Eur J Pharm Sci. 2018 Oct 15;123:475-483. doi: 10.1016/j.ejps.2018.07.061. Epub 2018 Aug 1.
8
A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling.一种以干粉形式肺部递送脂质体以消除研磨有害影响的新方法。
J Pharm Sci. 2002 Feb;91(2):482-91. doi: 10.1002/jps.10021.
9
Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.干粉吸入器:含有硫酸沙丁胺醇的乳糖配方的机械评估。
Int J Pharm. 2012 Feb 28;423(2):184-94. doi: 10.1016/j.ijpharm.2011.12.018. Epub 2011 Dec 17.
10
Stability of collapse lyophilized influenza vaccine formulations.冻干流感疫苗制剂的崩解稳定性。
Int J Pharm. 2015 Apr 10;483(1-2):131-41. doi: 10.1016/j.ijpharm.2015.01.053. Epub 2015 Feb 7.

引用本文的文献

1
Aerosolized Intratracheal Inoculation of Recombinant Protective Antigen (rPA) Vaccine Provides Protection Against Inhalational Anthrax in B10.D2-Hc Mice.气溶胶气管内接种重组保护性抗原(rPA)疫苗可预防 B10.D2-Hc 小鼠吸入性炭疽。
Front Immunol. 2022 Jan 26;13:819089. doi: 10.3389/fimmu.2022.819089. eCollection 2022.
2
Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B.用于口服乙肝疫苗的含乙肝表面抗原植物组织的冻干处理。
Biomed Res Int. 2014;2014:485689. doi: 10.1155/2014/485689. Epub 2014 Oct 12.

本文引用的文献

1
A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.一种新型干粉流感疫苗及鼻内递送技术:在大鼠中诱导全身和黏膜免疫反应
Vaccine. 2004 Dec 21;23(6):794-801. doi: 10.1016/j.vaccine.2004.06.049.
2
Factory's loss of licence halves supply of flu vaccine to US.工厂执照被吊销,导致美国流感疫苗供应量减半。
BMJ. 2004 Oct 16;329(7471):876. doi: 10.1136/bmj.329.7471.876-b.
3
Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.流感疫苗粉末制剂的研发:喷雾冷冻干燥及稳定性评估
J Pharm Sci. 2004 Jul;93(7):1912-23. doi: 10.1002/jps.20104.
4
Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.用于表皮粉末免疫的明矾吸附疫苗粉末制剂的优化。
Pharm Res. 2003 Jul;20(7):969-77. doi: 10.1023/a:1024493719236.
5
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus.
Vaccine. 2003 Jun 20;21(21-22):2805-12. doi: 10.1016/s0264-410x(03)00224-x.
6
Fundamentals of pulmonary drug delivery.肺部药物递送的基础
Respir Med. 2003 Apr;97(4):382-7. doi: 10.1053/rmed.2002.1457.
7
Feasibility of aerosol vaccination in humans.
Ann Otol Rhinol Laryngol. 2003 Mar;112(3):264-70. doi: 10.1177/000348940311200313.
8
Nasal drug delivery: new developments and strategies.鼻腔给药:新进展与策略
Drug Discov Today. 2002 Dec 1;7(23):1184-9. doi: 10.1016/s1359-6446(02)02529-1.
9
Chitosan as a novel nasal delivery system for vaccines.壳聚糖作为一种新型的疫苗鼻腔给药系统。
Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5.
10
A powder formulation of measles vaccine for aerosol delivery.用于气溶胶递送的麻疹疫苗粉末制剂。
Vaccine. 2001 Mar 21;19(17-19):2629-36. doi: 10.1016/s0264-410x(00)00503-x.